Rate My Professor Tianjing Li

Tianjing Li, MD, MHS, PhD, is a Professor in the Department of Ophthalmology, School of Medicine, at the University of Colorado Anschutz Medical Campus, with a secondary appointment as Associate Professor in the Department of Epidemiology, Colorado School of Public Health. She received her MD from West China Medical Center, Sichuan University in 2004, followed by an MHS in Biostatistics and a PhD in Epidemiology from Johns Hopkins Bloomberg School of Public Health in 2010. Before joining CU Anschutz in 2019, she held positions at Johns Hopkins as Assistant Scientist (2010-2012), Assistant Professor (2012-2017), and Associate Professor (2017-2019) in the Department of Epidemiology, where she was also a core faculty member in the Center for Clinical Trials and Evidence Synthesis.

Dr. Li directs the Cochrane Eyes and Vision US Project since 2018 and serves as Coordinating Editor for Cochrane Eyes and Vision, with prior roles as Associate Director for Cochrane United States (2012-2018) and co-convener of the Cochrane Comparing Multiple Interventions Methods Group. Her research develops, evaluates, and disseminates methods for systematic reviews, network meta-analysis, clinical trials, comparative effectiveness research, and patient-centered outcomes research, funded by the National Institutes of Health, Patient-Centered Outcomes Research Institute, Agency for Healthcare Research and Quality, U.S. Food and Drug Administration, and others. She is Co-Editor-in-Chief of Trials, Methodological Editor for Annals of Internal Medicine, Reviews Editor for JAMA Ophthalmology, and Associate Scientific Editor for the second edition of the Cochrane Handbook for Systematic Reviews of Interventions. Dr. Li has authored National Academies of Sciences, Engineering, and Medicine reports and received the Bill Silverman Prize (Cochrane, 2021), Anne Anderson Award (Cochrane, 2019), and Inaugural Early Career Award from the Society for Research Synthesis Methodology (2016). Key publications include Cochrane reviews on topical corticosteroids for dry eye (2022) and non-biologic therapies for uveitis (2022), a meta-analysis on dry eye prevalence (JAMA Ophthalmology, 2022), and methodological works such as Innovations in data collection, management, and archiving for systematic reviews (Annals of Internal Medicine, 2015). She participates in data safety monitoring boards and advisory committees for clinical trials.